is initiated by ligand-induced receptor dimerization, tyrosine phosphorylation of the Tyk2 and Jak1 tyrosine kinases, and subsequent phosphorylation of the Stat1 and Stat2 proteins. The IFN-␣ receptor consists of at least two distinct subunits. One subunit, IFNAR1, has low affinity binding for interferon yet is required for signal transduction. We introduced mutations in the cytoplasmic domain of human IFNAR1 in order to identify residues involved in the mediation of biological responses. We took advantage of the species specificity of the interferon receptors by analyzing human IFN-␣-induced major histocompatibility complex class I antigen expression in mouse L929 cells stably transfected with mutant human receptors. The membrane proximal 60-amino acids were insufficient to signal a biological response even though within these residues Tyk2 and Stat2 binding sites have been identified. IFN-␣-induced receptor tyrosine phosphorylation was not critical for signaling because mutation of Tyr residues to Phe did not prevent the biological response to IFN-␣. The deletion of a 16-amino acid region highly homologous between species created a receptor which signals an enhanced response. Tyrosine dephosphorylation is a component of this enhanced response as mutation of the Tyr residues within this region to Phe resulted in a receptor with increased sensitivity to IFN. The known signaling molecules that interact with IFNAR1 are positive regulators of IFN-␣ function. The presence of this domain in the COOH-terminal region suggests that the receptor may interact with signaling molecules that negatively regulate interferon responses.
The human interferon-␣ receptor (hIFN-␣R) 1 is a multichain receptor complex which binds the multiple human type I interferons with high affinity in a species-specific manner. A cDNA for one chain of the hIFN-␣R, hIFNAR1, encodes a receptor protein which contains an extracellular domain of 409 amino acids, a single transmembrane domain of 21 amino acids, and a 100-amino acid IC domain. Transfection of the hIFNAR1 cDNA into mouse BTG9A cells confers sensitivity to the antiviral action of hIFN-␣8 but not to the action of other human interferons such as hIFN-␣2 or hIFN-␤ (1) .
Transfection of the hIFNAR1 cDNA into mouse cells results in cell surface expression of the receptor but no detectable binding sites for hIFN-␣ (2, 3). Mice in which the gene for IFNAR1 has been inactivated by homologous recombination are unresponsive to all type I interferons and are unable to mount an effective antiviral defense (4, 5) . These findings suggest that IFNAR1 is a signal-transducing chain of the multicomponent receptor complex which has low affinity binding for most IFN-␣ subspecies yet is essential for type I interferon mediated responses.
Type I interferons induce the transcription of interferonstimulated genes through the formation and activation of ISRE-binding proteins. One of these binding proteins, ISGF3, is a multi-subunit protein complex that is formed in the cytoplasm within minutes of treatment with IFN-␣. The ISGF3 complex is composed of the 113-kDa Stat2 protein and the 91-kDa Stat1␣ or 84-kDa Stat1␤ protein associated with a p48 DNA-binding molecule (6 -8) . Stat1 and Stat2 become rapidly tyrosine-phosphorylated following IFN-␣ treatment and form heterodimeric complexes which translocate to the nucleus (9) . IFN-␣ treatment activates the Jak1 and the Tyk2 proteintyrosine kinases which are important in the formation of the phosphorylated ISGF3 complex (10, 11) . Tyk2 has been shown to be constitutively associated with the hIFNAR1 chain and in vitro Tyk2 can phosphorylate IFNAR1 (12, 13) . It is not clear which kinase(s) is responsible for the phosphorylation of the Stat proteins.
The IC domain of the hIFNAR1 chain contains four tyrosine residues which can act as potential phosphoryl acceptor sites. These tyrosines are located in two clusters, one pair (Tyr-466, Tyr-481) in a membrane proximal region and the other pair (Tyr-527, Tyr-538) in the carboxyl-terminal region. Recent experiments utilizing glutathione S-transferase fusion proteins of wild-type and mutant hIFNAR1 have shown that Tyr-466 and to a lesser extent Tyr-481, can be phosphorylated by the Tyk2 kinase (14) . These phosphorylated fusion proteins or receptor specific phosphopeptides provide recognition sites for binding of latent Stat2 (15) . Stat2 is then phosphorylated and binds with the Stat1␣ or Stat1␤ molecules (8) . When mutant versions of the IFNAR1 subunit in which Tyr-466 has been changed to Phe are transiently transfected into 293 cells, IFN-␣-dependent tyrosine phosphorylation of Stat2 is blocked. Thus the region surrounding Tyr-466 on the IFNAR1 subunit can associate with Stat2. Phosphopeptides containing the two distal tyrosine residues, Tyr-527 and Tyr-538 do not bind Stat1 or Stat2 and glutathione S-transferase fusion proteins containing these residues are not phosphorylated by the Tyk2 kinase. A role or function for these residues has not been identified. * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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The IC domain of the IFNAR1 contains two regions which have identical amino acid sequences in the bovine, human, and mouse IFNAR1 chains (16) . The first region is a 6-amino acid sequence, CFIIEN, located at positions 502-507 in the human receptor. These residues are located within a critical 25-amino acid region (positions 486 -511) that is necessary for Tyk2 binding activity (14) . Mutagenesis of the hydrophobic residues, IIE, to alanine abrogates Tyk2 and IFNAR1 phosphorylation. The second region is a 16-amino acid sequence, KYSSQTSQDS-GNYSNE, which contains the two distal tyrosine residues separated by 10 amino acids and is located near the carboxyl terminus.
We sought to identify regions in the IC domain of hIFNAR1 which are important in the generation of a biological response to hIFN-␣. We constructed a series of mutant hIFNAR1 cDNAs in an expression vector, transfected each expression vector into the murine L929 cell line, and treated stable transfectants with hIFN-␣8 or hIFN-␣2a. Biological responses to the human interferons were analyzed with murine MHC class I antigen expression as determined by fluorescence flow cytometry, transcriptional activation of the two IFN-␣-induced genes, PKR and 2Ј,5Ј-OAS, and with analysis of the formation of an activated ISGF3 DNA-protein binding complex. In this report we document that deletion of the conserved 16-amino acid distal region or substitution of the two Tyr residues within this region to Phe, leads to enhanced interferon-mediated responses. This region may interact with signaling molecules which play a negative role in the regulation of interferon activity.
EXPERIMENTAL PROCEDURES
Reagents-Recombinant hIFN-␣8 (1.97 ϫ 10 8 units/mg) was provided by David Gangemi, Clemson University, Clemson, SC, and hIFN␣2a (3 ϫ 10 6 units/ml; 2 ϫ 10 8 units/mg) was purchased from Roche Pharmaceuticals, Nutley, NJ. Murine IFN-␥ and purified murine monoclonal antibodies (mAb 2036 and mAb 2040) specific for the hIFNAR1 chain were supplied by Genentech Inc., South San Francisco, CA. Purified murine monoclonal antibody H-2K k , specific for murine MHC class I antigen was purchased from Becton Dickinson, Mountain View, CA. Phycoerytherin-conjugated goat anti-mouse IgG F(abЈ) 2 was purchased from Caltag, South San Francisco, CA.
Plasmid Construction and DNA Transfection-A 1,823-base pair fragment, containing the entire coding region of the hIFNAR1 cDNA, was inserted into the mammalian cell expression vector pRSV. A silent mutation created by PCR at position 461 generated a unique AflII site in the IC domain. This construct is designated pRSV-HAR. cDNAs encoding mutant receptors were produced by a two-step PCR mutagenesis technique using pRSV-HAR as template with specific mutagenic primers, restriction enzyme digestion, and subsequent ligation into the pRSV-HAR vector at unique AflII and BamHI sites. The accuracy of all polymerase chain reaction-generated DNA was confirmed by supercoiled DNA sequencing using a dideoxy chain-termination technique. The murine fibroblast cell line L929 was cotransfected with 1 g of expression plasmid and 50 ng of pSVEneo DNA per dish by a liposomemediated transfection technique (DOTAP, Boehringher Mannheim). Forty-eight hours after transfection, cells were split and transfectants were selected in G418.
Cytofluorometric Analysis of hIFNAR1-expressing Clones-Twelve individual G418-resistant clones were analyzed for each construct. Cells (5 ϫ 10 5 ) from each clone were incubated with 1 g of 2036 for 1 h. Cells were washed, incubated with 2.5 l of phycoerytherin-conjugated goat anti-mouse IgG for 1 h, washed, and analyzed by immunofluorescence flow cytometry. At least three clones of each construct were saved. The three single clones which had the highest expression of hIFNAR1 were tested for a functional response to hIFN-␣. Cells (5 ϫ 10 4 ) from each clone were treated with medium alone or medium plus hIFN-␣8 (10 ng/ml) or medium plus hIFN-␣2a (10 ng/ml) for 72 h. MHC class I antigen expression was assessed by immunofluorescence flow cytometry. As a control to ensure competency of the downstream events in the MHC class I induction pathway, all cultures were treated in a similar manner with homologous mIFN-␥ and analyzed by flow cytometry. To determine the dose-response to hIFN-␣8 and hIFN-␣2a, cells were treated in duplicate with concentrations of IFN between 50 pg/ml and 100 ng/ml. Medium alone was used to measure the basal level of MHC class I antigen expression and 10 ng/ml mIFN-␥ was used to measure maximal MHC class I antigen expression. To obtain a value for the level of induction, the mean fluorescence intensity with medium alone was subtracted from each of the mean fluorescence intensities after treatment with hIFN-␣. The induction at each hIFN-␣ dose is expressed as a percentage of the maximal MHC class I antigen induction achieved with mIFN-␥.
Electrophoretic Mobility Shift Assay-Gel shift assays were performed using a 32 P-labeled double-stranded oligonucleotide containing the ISRE of ISG15 (17) . After appropriate interferon treatment, cells were lysed as described (18) . Analysis of DNA binding activity was performed by mixing 5 g of extract with 25,000 cpm of the doublestranded 32 P-labeled ISG15 probe, and 2 g of poly(dI-dC) (Pharmacia) in 15 l of 30 mM Tris-HCl, pH 7.5, containing 300 mM KCl, 15 mM MgCl 2 , 3 mM dithiothreitol, 30% glycerol, and incubated for 30 min at room temperature. The reaction mixtures were separated by electrophoresis through a 6% polyacrylamide gel and analyzed by autoradiography. The specificity of the interaction was determined by the inclusion of samples which contained 350 ng of the unlabeled ISG15 probe.
Northern Blot Analysis-Cells lines were treated for indicated time periods with different interferons as indicated. Total RNA was isolated with Trizol (Life Technologies, Inc.) and 10 -15 g subjected to electrophoresis on a 1% agarose/formaldehyde gel and transferred to nylon membranes. A 32 P-labeled probe was made by random priming of plasmid DNA for PKR which recognized a 9.5-kilobase mRNA. Two overlapping oligonucleotides were labeled and used for 2Ј,5Ј-OAS which recognized a 1.25-kilobase mRNA.
RESULTS
Mouse fibroblast L929 cells constitutively express murine MHC class I antigen and do not respond to hIFN-␣8 or hIFN␣2a. We transfected L929 cells with the vector pRSV-HAR, which encodes the cDNA for the hIFNAR1, and established a stable cell line (HAR3) which expresses the full-length hIF-NAR1 chain. After incubation of the HAR3 cell line with 10 ng of hIFN-␣8/ml, an increase in murine MHC class I antigen expression can be demonstrated. There is no response to hIFN␣2a (Fig. 2, wild-type) . To obtain a value to compare the level of MHC class I induction after IFN treatment the mean fluorescence intensity with medium alone was subtracted from the mean fluorescence intensity after treatment with IFN. As seen in Fig. 2 , wild-type, the mean fluorescence intensity of cells in medium alone is 32, after hIFN-␣8 treatment the mean fluorescence intensity increased to 58. This represents a ⌬ mean fluorescence intensity of 26. A ⌬ mean fluorescence intensity greater than 10 is considered a positive response. Thus, in the presence of the hIFNAR1 chain, hIFN-␣8 will signal a biological response in a mouse cell line.
Six cDNAs were constructed that encode receptor mutants with truncations or deletions that span regions of the IC domain (Fig. 1) . Each construct was transfected into the mouse L929 cell line and stable cell lines established. Fig. 2 illustrates the level of hIFNAR1 expression from a representative clone for each mutant as determined by immunofluorescence flow cytometry using mAb 2036.
The cell lines which express a mutant hIFNAR1 were tested for their ability to respond to hIFN-␣8 or hIFN-␣2a. Each cell line has a different level of endogenous MHC class I antigen expression which is a reflection of clonal variation. The four cell lines which contain truncated receptors do not respond to either hIFN-␣8 or hIFN-␣2 yet remain responsive to mIFN-␥, indicating that there is no defect in the general pathway of MHC class I induction (Fig. 2, A-D) . This indicates that most of the IC domain is required for a biological response even though the HAR⌬519 -557 mutant contains potential Tyk2 and Stat2 binding regions. The cell line which contains the receptor with the deleted 6-amino acid conserved region, HAR⌬502-507, responds to hIFN-␣8 (Fig. 2, E) . After treatment with IFN, the cell line which contains the 16-amino acid deletion, HAR⌬525-544, demonstrates an increase in MHC class I antigen expression that is greater than the response of the wild-type receptor. This cell line also responds to 10 ng of hIFN-␣2a per ml (Fig. 2,  F) . All clones tested showed a similar response to IFN treat- ment. The response of three clones after hIFN-␣8 treatment showed a ⌬ mean fluorescence intensity value of 66 Ϯ 20 and after hIFN-␣2a treatment a ⌬ mean fluorescence intensity value of 20 Ϯ 10. The enhanced responsiveness is not associated with increased hIFNAR1 receptor number since this mutant exhibited the same degree of hIFNAR1 expression as the wild-type receptor. It is possible that these changes in the IC domain alter the affinity of ligand for the receptor or that receptor internalization is altered.
To test further the response of HAR⌬525-544 to hIFN-␣8 and to hIFN-␣2a we measured dose responses for the induction of MHC class I antigen expression (Fig. 3) . For the wild-type receptor in HAR3, a functional response to hIFN-␣8 is first detected at a concentration of 100 pg/ml (Fig. 3, open circles) . For the mutant receptor expressed on HAR⌬525-544 the response to hIFN-␣8 (Fig. 3, open squares) is greater at all concentrations tested than the response in HAR3 to hIFN-␣8. Very large doses would be required to elicit a response to hIFN-␣2a on the wild-type receptor (Fig. 3, closed circles) while the mutant cell line responds to hIFN-␣2a at concentrations beginning at 5 ng/ml (Fig. 3, closed squares) . The mutant receptor demonstrates increased sensitivity to both interferons which have the same relative specific activities on the mutant receptor as on the wild-type receptor.
We investigated the formation of an activated ISGF3 complex in the wild-type hIFNAR1 cell line (HAR3) and in the HAR⌬525-544 mutant cell line. At various times after hIFN-␣8 addition, nuclear extracts from the HAR3 and HAR⌬525-544 cell lines were made and gel shift assays performed using an ISRE probe. For the HAR3 cell line, formation of an activated complex is observed after 15 min of treatment with hIFN-␣8 and continues to be present after 2 h of interferon treatment. For the HAR⌬525-544 cell line the kinetics of formation of the ISGF3 complex are the same but there is an enhanced response (Fig. 4) . We looked at the persistence of the nuclear complex after pulsing the cells for 15 min with IFN-␣8 and then removing the interferon. We found that there was no difference between the two cell lines and that the complex persisted for 2 h in both cases (data not shown).
HAR3 and HAR⌬525-544 cells were treated for various times with 10 ng of hIFN-␣8/ml and total RNA isolated. The expression of murine 2Ј,5Ј-OAS and murine PKR was examined by Northern blot analysis. After 6 h of interferon treatment there is higher expression of both mRNAs in the mutant cells when compared with cells expressing the wild-type receptor while the kinetics of expression do not differ between the two cell lines (Fig. 5) .
To determine if tyrosine phosphorylation of the receptor is involved in the generation of a biological response, seven receptor cDNAs were created which contain individual Tyr to Phe point mutations at each position and two Tyr to Phe point mutations in combination (Fig. 6, top panel) . Each construct was transfected into the mouse L929 cell line and stable cell lines established. Fig. 6 (middle panel) illustrates the level of hIFNAR1 expression from a representative clone as determined by immunofluorescence flow cytometry using mAb 2036. The cell lines which express a mutant hIFNAR were tested for their ability to respond to hIFN-␣8 and hIFN-␣2a by quantitating the enhancement of murine MHC class I antigen expression. With one exception, none of the Tyr to Phe mutant cell lines were altered in their ability to signal in response to hIFN-␣8 (Fig. 6, lower panel) . The exception is the cell line which contains a substitution of both distal Tyr residues with Phe (HAR-Y527F,Y538F); this mutant receptor signaled a response greater than the response of the wild-type receptor. As seen with the cell line HAR⌬525-544, a response to 10 ng of hIFN␣2a/ml is detectable (Fig. 6, L, lower panel) . Formation of an activated ISGF3 complex is observed in the HAR-Y466F,Y481F cell line after hIFN-␣8 treatment and in the HAR-Y527F,Y538F cell line. The response is greater in the cell line which contains the distal Tyr to Phe mutations (Fig. 7) . These findings suggest that tyrosine phosphorylation of IFNAR1 is involved in the modulation of an interferon response but is not required for function.
DISCUSSION
IFNAR1 is one chain of the multi-component IFN-␣R. When hIFNAR1 is transfected into mouse cells, the cells become responsive to hIFN-␣8. We have utilized the ability of these transfected mouse cells to respond to a human interferon to probe the functional consequences of alterations in the cytoplasmic domain of the hIFNAR1. We constructed receptors containing truncated or mutated forms of the cytoplasmic domain and examined the resulting cell lines ability to mount an increase in MHC class I antigen expression after treatment with hIFN-␣.
The cell line HAR⌬463-557 encodes a truncated form of the receptor that lacks all but the first 5 amino acids of the IC domain. HAR⌬477-557 encodes a truncated form of the receptor that contains the first Tyr (Tyr-466) and the adjoining 10-amino acid region (13) . HAR⌬492-557 contains both membrane proximal Tyr residues (Y466Y,Y481Y) but lacks the conserved CFIIEN region important for Tyk2 binding (14) . HAR⌬519 -557 contains both membrane proximal Tyr residues and the conserved 6-amino acid region but lacks the distal 40 residues of the IC domain. All of these mutant receptors were unable to signal a biological response after treatment with hIFN-␣. This suggests that the IFNAR1 regions required for Tyk2 binding are insufficient for signaling a biological response and that additional distal residues are required. These distal residues may be important in the interaction with the other chains of the IFN-␣R complex or with other signaling molecules or the truncation of the receptor may cause structural changes that prevent signaling.
Recent studies have shown that Tyr-466 in the hIFNAR1 can bind Stat2 but a Stat2 consensus binding site has not been defined (15) . It is not known if Tyr-466 is a Stat2 binding site in vivo or whether there are other Stat2 binding regions in the receptor complex. Mutation of Tyr-466 to Phe in our experiments results in a functional receptor. Similarly mutation of all Tyr residues to Phe results in receptor able to signal. This suggests that receptor phosphorylation is not necessary for the generation of a biological response. Similar findings have been reported with the growth hormone receptor (19) . Tyrosine phosphorylation of the growth hormone receptor has been shown to be associated with Jak2 kinase activation and Stat1 activation, yet mutation of the seven Tyr residues to Phe result in a receptor still able to signal a proliferative response. Similarly in the IL-10R, which is a member of the IFN receptor family (20) , mutation of each of the four Tyr residues to Phe results in receptors able to signal a proliferative response to IL-10 that is equal to the response mediated by the wild-type receptor (21) . In the experimental system we have employed with the hIFNAR1, the transfected human receptor transduces an hIFN-␣8 signal in conjunction with the mouse IFN-␣R components. It is possible that in the activation process, the endogenous mouse IFNAR1 has been activated and can substitute for a phosphorylated hIFNAR1. Alternatively other IFN-␣R subunits may provide phosphorylation sites suitable for Stat binding and activation.
A second region of interest in the IFNAR1 lies within the carboxyl-terminal 25 amino acids. This region contains a highly conserved 16-amino acid domain, deletion of which leads to increased sensitivity to interferon. These findings can be recapitulated by the mutation of the two resident tyrosines at positions 527 and 538 to phenylalanine. This result suggests that IFNAR1 phosphorylation is important in determining the magnitude of a biological response to IFN-␣. It is of interest that the IL-10R also contains a negative regulatory region in the cytoplasmic domain of the receptor (21) . In the IL-10R, deletion of residues 282-389 (which are in a membrane proximal region) results in a superactivating IL-10R; cells expressing this mutant IL-10R were 30 -100-fold more sensitive to IL-10 in a proliferation assay than cells with a wild-type receptor. The property of superactivation was not associated with altered ligand affinity or IL-10R number nor impairment of the ability to internalize ligand (21) .
Another example of a negative regulatory region lies within the erythropoietin receptor where recent studies have defined a role for an erythropoietin receptor-associated SH2 domain-containing phosphatase (22) . This phosphatase, HCP, is targeted to phosphorylated Tyr-429 in the erythropoietin receptor. Deletion or mutation of this tyrosine residue leads to persistant Jak2 phosphorylation demonstrating that this Jak kinase is a substrate for the HCP phosphatase and implicates this phosphatase as being essential to the termination of an erythropoietin induced response. A role for a membrane-associated tyrosine phosphatase has been reported in the IFN-␣ signaling pathway (23) . The tyrosine phosphatase HCP has been shown to form stable complexes with Tyk2 in hematopoietic cell lines and the IFN-␣-induced tyrosine-phosphorylated form of Tyk2 can be a substrate for the phosphatase activity of HCP in vitro (24) . Others have found that HCP is basally associated with IFNAR1 but reversibly dissociates upon IFN addition (25) . Based upon binding studies with IFNAR1 fusion proteins, the phosphatase appears to associate with the membrane proximal region (26) . These studies suggest that IFNAR1 may associate with an SH2 domain-containing tyrosine phosphatase and interact with the Tyk2 receptor-associated kinase. We have examined this possibility in the mutant cell lines created here but do not find the presence of HCP in our cell lines and do not see any differential phosphorylation of the Tyk2 kinase in the mutant cell lines when compared with the cell line which expresses a wild-type receptor (data not shown).
The biological effect of a specific interferon is directly proportional to the degree of interferon binding and differences in receptor affinity for the different interferon species can be overcome by increasing the dosage of the interferon to achieve the same biological effect (27) . Human IFN-␣2a binding to hIFNAR1 cannot be obtained and hIFN-␣8 binding to hIF-NAR1 has been difficult to determine even though receptor expression can be demonstrated (2, 3) . We show that the cell line which contains the wild-type receptor does not respond to hIFN-␣2a and infer that the receptor has lower affinity for hIFN-␣2a than for hIFN-␣8. The mutant receptor expressed on HAR⌬525-544 demonstrates the same relationship between the two interferons; cells are more responsive to hIFN-␣8 than to hIFN-␣2a. It is possible that the increased sensitivity to both interferons in the mutant cell lines is a result of changes in the affinity of the receptor for ligand. We favor the interpretation that the mutations we have created in the receptor result in an alteration in the ability of signaling molecules or other receptor components to associate with the hIFNAR1. Such a scenario has been demonstrated in the U1A mutant cell line, which is unresponsive to IFN-␣ and has reduced binding activity to IFN-␣2 (28) . Complementation of this mutant cell line with the cDNA for Tyk2 restores full functional and binding activity (11) . Tyk2 can be co-immunoprecipitated with IFNAR1, highlighting the integral association between the receptor and the kinase (13) and restoration of IFN-␣2 binding is not dependent on kinase activation because a kinase-deficient mutant can restore IFN-␣2 binding, suggesting that there is a structural association between the kinase and the receptor (29) . Thus this receptor-associated component establishes the correct surface expression and/or association of the IFN-␣R subunits critical for binding. Our findings suggest that the conserved 16-amino acid COOH-terminal region may interact with an intracellular protein(s) which negatively regulates IFNAR1 activation. This molecule(s) could be a phosphatase, an adaptor protein linked to a phosphatase, another receptor protein(s), an unknown signaling molecule, or a new function for a known signaling molecule.
